Code First Notes in Chapter 10: Diseases of the respiratory system ICD-10-CM
A Code First note means the underlying condition named in the note is sequenced before this code. In Chapter 10 (J00-J99), notes printed in the chapter name other codes 75 times, and Code First Notes anywhere in the Tabular List name the chapter’s codes 35 times, covering 20 distinct codes, categories and ranges. Switch views to read the list either way.
Code First Notes by the code that carries the note
- J12.82 Pneumonia due to coronavirus disease 2019
- COVID-19 (U07.1)
- J13 Pneumonia due to Streptococcus pneumoniae
- J14 Pneumonia due to Hemophilus influenzae
- J17 Pneumonia in diseases classified elsewhere
- deviated nasal septum (J34.2)
- J44.81 Bronchiolitis obliterans and bronchiolitis obliterans syndrome
- J68 Respiratory conditions due to inhalation of chemicals, gases, fumes and vapors applies to 7 codes
- J69.1 Pneumonitis due to inhalation of oils and essences
- J69.8 Pneumonitis due to inhalation of other solids and liquids
- J70.5 Respiratory conditions due to smoke inhalation
- smoke inhalation (T59.81-)
- J70.8 Respiratory conditions due to other specified external agents
- J70.9 Respiratory conditions due to unspecified external agent
- J82.83 Eosinophilic asthma
- J84.03 Idiopathic pulmonary hemosiderosis
- disorders of iron metabolism (E83.1-)
- J84.170 Interstitial lung disease with progressive fibrotic phenotype in diseases classified elsewhere
- J84.178 Other interstitial pulmonary diseases with fibrosis in diseases classified elsewhere
- J84.89 Other specified interstitial pulmonary diseases
- J91.0 Malignant pleural effusion
- J91.8 Pleural effusion in other conditions classified elsewhere
- J93.12 Secondary spontaneous pneumothorax
- catamenial pneumothorax due to endometriosis (N80.B-)
- cystic fibrosis (E84.-)
- eosinophilic pneumonia (J82.81-J82.82)
- lymphangioleiomyomatosis (J84.81)
- malignant neoplasm of bronchus and lung (C34.-)
- Marfan syndrome (Q87.4-)
- pneumonia due to Pneumocystis carinii (B59)
- secondary malignant neoplasm of lung (C78.0-)
- spontaneous rupture of the esophagus (K22.3)
- J98.51 Mediastinitis
- underlying condition, if applicable, such as postoperative mediastinitis (T81.-)
- J99 Respiratory disorders in diseases classified elsewhere
- J06.9 Acute upper respiratory infection, unspecified
- B97.4 Respiratory syncytial virus as the cause of diseases classified elsewhere: upper respiratory infection (J06.9)
- J09.X1 Influenza due to identified novel influenza A virus with pneumonia
- J12 Viral pneumonia, not elsewhere classified: associated influenza, if applicable (J09.X1, J10.0-, J11.0-)
- J13 Pneumonia due to Streptococcus pneumoniae: , if applicable, associated influenza (J09.X1, J10.0-, J11.0-)
- J14 Pneumonia due to Hemophilus influenzae: , if applicable, associated influenza (J09.X1, J10.0-, J11.0-)
- J15 Bacterial pneumonia, not elsewhere classified: , if applicable, associated influenza (J09.X1, J10.0-, J11.0-)
- J16 Pneumonia due to other infectious organisms, not elsewhere classified: , if applicable, associated influenza (J09.X1, J10.0-, J11.0-)
- J18 Pneumonia, unspecified organism: , if applicable, associated influenza (J09.X1, J10.0-, J11.0-)
- J09.X2 Influenza due to identified novel influenza A virus with other respiratory manifestations
- J91.8 Pleural effusion in other conditions classified elsewhere: influenza (J09.X2, J10.1, J11.1)
- J12 Viral pneumonia, not elsewhere classified: associated influenza, if applicable (J09.X1, J10.0-, J11.0-)
- J13 Pneumonia due to Streptococcus pneumoniae: , if applicable, associated influenza (J09.X1, J10.0-, J11.0-)
- J14 Pneumonia due to Hemophilus influenzae: , if applicable, associated influenza (J09.X1, J10.0-, J11.0-)
- J15 Bacterial pneumonia, not elsewhere classified: , if applicable, associated influenza (J09.X1, J10.0-, J11.0-)
- J16 Pneumonia due to other infectious organisms, not elsewhere classified: , if applicable, associated influenza (J09.X1, J10.0-, J11.0-)
- J18 Pneumonia, unspecified organism: , if applicable, associated influenza (J09.X1, J10.0-, J11.0-)
- J10.1 Influenza due to other identified influenza virus with other respiratory manifestations
- J91.8 Pleural effusion in other conditions classified elsewhere: influenza (J09.X2, J10.1, J11.1)
- J12 Viral pneumonia, not elsewhere classified: associated influenza, if applicable (J09.X1, J10.0-, J11.0-)
- J13 Pneumonia due to Streptococcus pneumoniae: , if applicable, associated influenza (J09.X1, J10.0-, J11.0-)
- J14 Pneumonia due to Hemophilus influenzae: , if applicable, associated influenza (J09.X1, J10.0-, J11.0-)
- J15 Bacterial pneumonia, not elsewhere classified: , if applicable, associated influenza (J09.X1, J10.0-, J11.0-)
- J16 Pneumonia due to other infectious organisms, not elsewhere classified: , if applicable, associated influenza (J09.X1, J10.0-, J11.0-)
- J18 Pneumonia, unspecified organism: , if applicable, associated influenza (J09.X1, J10.0-, J11.0-)
- J11.1 Influenza due to unidentified influenza virus with other respiratory manifestations
- J91.8 Pleural effusion in other conditions classified elsewhere: influenza (J09.X2, J10.1, J11.1)
- J34.2 Deviated nasal septum
- J34.82 Nasal valve collapse: deviated nasal septum (J34.2)
- I21.A1 Myocardial infarction type 2: chronic obstructive pulmonary disease (J44.-)
- J82.83 Eosinophilic asthma: mild intermittent asthma (J45.2-)
- J82.83 Eosinophilic asthma: mild persistent asthma (J45.3-)
- J82.83 Eosinophilic asthma: moderate persistent asthma (J45.4-)
- J82.83 Eosinophilic asthma: severe persistent asthma (J45.5-)
- F54 Psychological and behavioral factors associated with disorders or diseases classified elsewhere: asthma (J45.-)
- J84.170 Interstitial lung disease with progressive fibrotic phenotype in diseases classified elsewhere: lung diseases due to external agents (J60-J70)
- J93.12 Secondary spontaneous pneumothorax: eosinophilic pneumonia (J82.81-J82.82)
- J84.10 Pulmonary fibrosis, unspecified
- U09.9 Post COVID-19 condition, unspecified: pulmonary fibrosis (J84.10)
- J84.81 Lymphangioleiomyomatosis
- J93.12 Secondary spontaneous pneumothorax: lymphangioleiomyomatosis (J84.81)
- I76 Septic arterial embolism: lung abscess (J85.-)
- U09.9 Post COVID-19 condition, unspecified: chronic respiratory failure (J96.1-)
The first view lists notes printed in this chapter (a note on a category or block applies to every code beneath it). The second lists codes of this chapter named by Code First Notes anywhere in the Tabular List, including notes in other chapters.
Questions About Code First Notes
What does a Code First note mean?
A Code First note means the underlying condition named in the note is sequenced before the code that carries the note. Under the etiology/manifestation convention, a “code first” note appears at the manifestation code and a “use additional code” note at the etiology code (Section I.A.13). The FY 2027 Tabular List has 810 of them; 600 name other codes, with 736 references to 429 distinct codes, categories and ranges.
Can a code with a Code First note be the principal diagnosis?
Not when it is a manifestation code. Codes titled “in diseases classified elsewhere” are never permitted as the first-listed or principal diagnosis; they must follow the underlying condition. The etiology and manifestation page lists them all.
Related References
Source: FY 2027 ICD-10-CM Tabular List (CMS and NCHS) and the ICD-10-CM Official Guidelines for Coding and Reporting FY 2027, Section I.A. ICD List is not affiliated with CMS or NCHS.